HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Spondyloepiphyseal dysplasia with nephrotic syndrome (Schimke immunoosseous dysplasia).

Abstract
The first symptoms of immunooseous dysplasia were growth retardation and myopia. Nephrotic syndrome was diagnosed at the age of 8 years. Skeletal roentgenograms showed spondyloepiphyseal dysplasia. In the renal biopsy there was nodular accumulations of PAS-positive hyaline material at the base of the granular stalks. There was lymphopenia with decreased CD4 and CD8 subpopulations. The condition of the patient gradually worsened until she died unexpectedly at 10 years with clinical symptoms of encephalitis. Autopsy documented cytomegaloviral pneumonia and advanced mesangioproliferative glomerulonephritis. In the spleen there was PAS-positive hyaline material massively infiltrating the walls of the central arterioles of the splenic follicles. There was marked depletion of lymphocytes in the spleen and in lymph nodes. The differential diagnosis of immunooseous dysplasia in the framework of spondyloepiphyseal dysplasia is discussed.
AuthorsA Santavá, J Zapletalová, K Michálková, S Hanáková, F Kopriva, J Santavý, J Dusek, D Kleinová
JournalAmerican journal of medical genetics (Am J Med Genet) Vol. 49 Issue 3 Pg. 270-3 (Feb 01 1994) ISSN: 0148-7299 [Print] United States
PMID8209884 (Publication Type: Case Reports, Journal Article)
Topics
  • Child
  • Diagnosis, Differential
  • Female
  • Growth Disorders (complications, genetics)
  • Humans
  • Immunologic Deficiency Syndromes (complications, genetics)
  • Myopia (complications, genetics)
  • Nephrotic Syndrome (complications, genetics)
  • Osteochondrodysplasias (complications, diagnosis, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: